PROMACULA® omega
Your product for treating AMD in combination with »dry eyes« (keratoconjunctivitis sicca).
According to the results of clinical studies, taking PROMACULA® omega on a regular basis can slow down the progression of AMD (age-related macular degeneration).
The omega-3 fatty acids in PROMACULA® omega can also support the production of lacrimal fluid.
PROMACULA® offers an evidence-based AMD treatment
Formulation of PROMACULA® omega was determined in accordance with the AREDS2 formula, thus complying with the criterion for evidence-based AMD treatment. The ingredients, as well as the dosage, have been carefully selected in accordance with extensive studies based on years of research.
PROMACULA® represents premium quality
The products from Lenus Pharma are manufactured in accordance with the pharmaceutical standard (pharmaceutical GMP). This sets the highest quality standards, starting from the selection of raw materials through to the finished product.
PROMACULA® omega is suitable for patients with AMD who suffer from “dry eyes”.
In addition to the AREDS2 formulation, the added 1,000 mg of omega-3 fatty acids (daily dose) assists with “dry eyes”.
| AREDS2 recommendation | 100% AREDS2 | |
|---|---|---|
|
Vitamin C
|
500 mg
|
|
|
Vitamin E
|
400 I.U.
|
|
|
Zinc
|
25/80 mg
|
|
|
Copper
|
2 mg
|
|
|
Lutein
|
10 mg
|
|
|
Zeaxanthin
|
2 mg
|
|
|
Omega-3 fatty acids
|
1.000 mg
|
|
| *I.u. = International units | ||
